DGAP-News: Zyomyx Closes Series 2 Preferred Financing Round of $12 Million to Enable Launch of Low-Cost, Rapid Point-of-Care CD4 Test

Zyomyx, Inc. 30.06.2013 07:00 --------------------------------------------------------------------------- Novel Diagnostic Will Expand Access to HIV Treatment FREMONT, Calif., 2013-06-30 07:00 CEST (GLOBE NEWSWIRE) -- Zyomyx, Inc. announced today that it completed the first closing of its Series ...